Seattle Genetics Inc (NASDAQ:SGEN)

115.35
Delayed Data
As of 4:00pm ET
 +3.65 / +3.27%
Today’s Change
62.90
Today|||52-Week Range
122.36
+0.95%
Year-to-Date
Are Biotech Stocks Due for a Correction in 2020?
Jan 15 / MotleyFool.com - Paid Partner Content
These 3 Biotech Stocks Could Be Top Stocks in 2020
Jan 11 / MotleyFool.com - Paid Partner Content
Why Seattle Genetics Stock Skyrocketed 102% in 2019
Jan 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close111.70
Today’s open111.90
Day’s range111.00 - 115.75
Volume1,194,565
Average volume (3 months)1,134,996
Market cap$18.7B
Data as of 4:00pm ET, 01/23/2020

Growth & Valuation

Earnings growth (last year)-61.10%
Earnings growth (this year)-9.37%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+35.76%
P/E ratioNM
Price/Sales13.64
Price/Book13.70

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-0.24-0.31%
GLPGGalapagos NV-3.40-1.44%
ALXNAlexion Pharmaceutic...-2.85-2.56%
ALNYAlnylam Pharmaceutic...+2.33+2.02%
Data as of 4:00pm ET, 01/23/2020

Financials

Next reporting dateFebruary 13, 2020
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$654.7M
Annual profit (last year)-$222.7M
Net profit margin-34.01%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Bothell, Washington

Forecasts